Home / Posts Tagged "pharmaceutical"

Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received final approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine Dimesylate Capsules in strengths

READ MORE

Mankind Pharma, a renowned global pharmaceutical company, has set up a comprehensive healthcare camp at the Mahakumbh 2025 in Prayagraj, Uttar Pradesh, India, offering essential medical services and support to thousands of pilgrims. The initiative, which commenced on 13th January and will continue through to

READ MORE

Granules India Ltd., a vertically integrated pharmaceutical company, today announced its financial results for the quarter ended December 31, 2024. Financial Summary (All numbers in INR Mn., except Margins)   QUARTERLY CONSOLIDATED FINANCIALS Q3FY25 Q2FY25 Growth (QoQ) Q3FY24 Growth (YoY) Revenue from Operations 11,377 9,666 18% 11,556 -2% EBITDA 2,303 2,033 13% 2,505 -8% EBITDA % 20% 21%   22%   PAT 1,176 972 21% 1,257 -6% PAT % 10% 10%   11%     Financial and Business Summary for Q3FY25 The Company voluntarily paused

READ MORE

Dr Mahesh D M, Consultant Endocrinologist, Aster CMI Hospital Ozempic is currently one of the most popular drugs on the market, with many Hollywood as well as Bollywood celebs allegedly using it to lose weight. Recently on Christmas, Tesla and SpaceX CEO Elon Musk took to

READ MORE

A national conference focusing on "Enhancing Pharmaceutical Quality Assurance through Good Manufacturing Practices (GMP)" brought together policymakers, industry leaders, and regulators at Andhra Pradesh MedTech Zone (AMTZ) today. Organized by the PHD Chamber of Commerce and Industry (PHDCCI) in collaboration with the Department of Pharmaceuticals,

READ MORE

The Indian pharmaceutical sector is strategically poised to capitalize on the recent healthcare initiatives introduced by President Donald Trump, aimed at enhancing the affordability and accessibility of medical treatments in the United States. This development presents significant opportunities for Indian drug manufacturers to expand their

READ MORE

Commitment to stringent European standards reinforces Venus Remedies’ leadership in antibiotics and oncology manufacturing while positioning the company for continued growth in global markets  Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a premier player in the global pharmaceutical industry, has announced the successful renewal of its

READ MORE

The Skill Development Centre aims to enhance the skills of community members Anyone in the community can enrol and gain relevant skills for employability The Skill Development Centre will train 600-720 candidates annually The Dr. Vijay Kumar Datla Foundation, the CSR arm of Biological E. Limited, in collaboration

READ MORE

A 3-Day Exhibition and Summit at Bombay Exhibition Centre, Supported by, Indian Drug Manufacturers’ Association (IDMA), Federation of Pharmaceutical and Allied Products Merchant Exports (FPME), Federation of Pharma Entrepreneurs (FOPE) and Leading Industry Associations The event will bring together 225+ exhibitors and showcase 12000+

READ MORE

Mankind Pharma Limited (BSE: 543904 | NSE: MANKIND) and Innovent Biologics have announced a groundbreaking partnership to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient

READ MORE